{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T10:13:26Z","timestamp":1766830406316,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:00:00Z","timestamp":1601078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:00:00Z","timestamp":1601078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s12185-020-03007-4","type":"journal-article","created":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T18:02:30Z","timestamp":1601143350000},"page":"609-613","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Secondary failure of platelet recovery in patients treated with high-dose thiotepa and busulfan followed by autologous stem cell transplantation"],"prefix":"10.1007","volume":"112","author":[{"given":"Fumiya","family":"Wada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4171-2162","authenticated-orcid":false,"given":"Momoko","family":"Nishikori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Hishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsumasa","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayoi","family":"Shimazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takero","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,26]]},"reference":[{"issue":"4","key":"3007_CR1","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00280-019-03914-2","volume":"84","author":"E Kondo","year":"2019","unstructured":"Kondo E, Ikeda T, Goto H, Nishikori M, Maeda N, Matsumoto K, et al. Pharmacokinetics of thiotepa in high-dose regimens for autologous hematopoietic stem cell transplant in Japanese patients with pediatric tumors or adult lymphoma. Cancer Chemother Pharmacol. 2019;84(4):849\u201360.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"3007_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/sj.bmt.1705820","volume":"40","author":"H Narimatsu","year":"2007","unstructured":"Narimatsu H, Emi N, Kohno A, Iwai M, Yanada M, Yokozawa T, et al. High incidence of secondary failure of platelet recovery after autologous and syngeneic peripheral blood stem cell transplantation in acute promyelocytic leukemia. Bone Marrow Transplant. 2007;40(8):773\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"3007_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/bbmt.2001.v7.pm11302549","volume":"7","author":"B Bruno","year":"2001","unstructured":"Bruno B, Gooley T, Sullivan KM, Davis C, Bensinger WI, Storb R, et al. Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2001;7(3):154\u201362.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"3007_CR4","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1182\/blood.V91.9.3509","volume":"91","author":"SH Bernstein","year":"1998","unstructured":"Bernstein SH, Nademanee AP, Vose JM, Tricot G, Fay JW, Negrin RS, et al. A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. Blood. 1998;91(9):3509\u201317.","journal-title":"Blood"},{"issue":"Suppl 1","key":"3007_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/stem.5530140734","volume":"14","author":"RA Nash","year":"1996","unstructured":"Nash RA, Gooley T, Davis C, Appelbaum FR. The problem of thrombocytopenia after hematopoietic stem cell transplantation. Stem Cells. 1996;14(Suppl 1):261\u201373.","journal-title":"Stem Cells"},{"issue":"1","key":"3007_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbmt.2016.09.024","volume":"23","author":"M Scordo","year":"2017","unstructured":"Scordo M, Bhatt V, Hsu M, Omuro AM, Matasar MJ, DeAngelis LM, et al. A comprehensive assessment of toxicities in patients with central nervous system lymphoma undergoing autologous stem cell transplantation using thiotepa, busulfan, and cyclophosphamide conditioning. Biol Blood Marrow Transplant. 2017;23(1):38\u2013433.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"3007_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.autrev.2007.11.005","volume":"7","author":"T Bohgaki","year":"2008","unstructured":"Bohgaki T, Atsumi T, Koike T. Autoimmune disease after autologous hematopoietic stem cell transplantation. Autoimmun Rev. 2008;7(3):198\u2013203.","journal-title":"Autoimmun Rev"},{"issue":"8","key":"3007_CR8","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.bbmt.2016.04.005","volume":"22","author":"Z Li","year":"2016","unstructured":"Li Z, Rubinstein SM, Thota R, Savani M, Brissot E, Shaw BE, et al. Immune-mediated complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2016;22(8):1368\u201375.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"3007_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2141.2012.09070.x","volume":"157","author":"A Holbro","year":"2012","unstructured":"Holbro A, Abinun M, Daikeler T. Management of autoimmune diseases after haematopoietic stem cell transplantation. Brit J Haematol. 2012;157(3):281\u201390.","journal-title":"Brit J Haematol"},{"issue":"10","key":"3007_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11912-019-0838-7","volume":"21","author":"TF Michniacki","year":"2019","unstructured":"Michniacki TF, Ebens CL, Choi SW. Immune-mediated cytopenias after hematopoietic cell transplantation: pathophysiology, clinical manifestations, diagnosis and treatment strategies. Curr Oncol Rep. 2019;21(10):87\u201397.","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"3007_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s12185-009-0261-1","volume":"89","author":"A Abdelkefi","year":"2009","unstructured":"Abdelkefi A, Jamil WB, Torjman L, Ladeb S, Ksouri H, Lakhal A, et al. Hemophagocytic syndrome after hematopoietic stem cell transplantation: a prospective observational study. Int J Hematol. 2009;89(3):368\u201373.","journal-title":"Int J Hematol"},{"issue":"8","key":"3007_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","volume":"40","author":"ED Batts","year":"2007","unstructured":"Batts ED, Lazarus HM. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? Bone Marrow Transplant. 2007;40(8):709\u201319.","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"3007_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/sj.bmt.1702658","volume":"26","author":"AP Jillella","year":"2000","unstructured":"Jillella AP, Kallab AM, Kutlar A. Autoimmune thrombocytopenia following autologous stem cell transplantation: review of literature and treatment options. Bone Marrow Transplant. 2000;26(8):925\u20137.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"3007_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/sj.bmt.1704073","volume":"32","author":"O Hequet","year":"2003","unstructured":"Hequet O, Salles G, Ketterer N, Espinouse D, Dumontet C, Thieblemont C, et al. Autoimmune thrombocytopenic purpura after autologous stem cell transplantation. Bone Marrow Transplant. 2003;32(1):89\u201395.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"3007_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/sj.bmt.1704574","volume":"34","author":"I Ahmad","year":"2004","unstructured":"Ahmad I, Haider K, Kanthan R. Autoimmune thrombocytopenia following tandem autologous peripheral blood stem cell transplantation for refractory germ cell tumor. Bone Marrow Transplant. 2004;34(3):279\u201380.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"3007_CR16","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.bbmt.2019.12.003","volume":"26","author":"U Mahat","year":"2020","unstructured":"Mahat U, Rotz S, Hanna R. Use of thrombopoietin receptor agonists in prolonged thrombocytopenia after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2020;26(3):e65\u201373.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"24","key":"3007_CR17","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1200\/JCO.2003.04.056","volume":"21","author":"H Pels","year":"2003","unstructured":"Pels H, Schmidt-Wolf IG, Glasmacher A, Schulz H, Engert A, Diehl V, et al. Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol. 2003;21(24):4489\u201395.","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-03007-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-020-03007-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-03007-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:12:38Z","timestamp":1632615158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-020-03007-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,26]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["3007"],"URL":"https:\/\/doi.org\/10.1007\/s12185-020-03007-4","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2020,9,26]]},"assertion":[{"value":"5 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"M. Nishikori has received honoraria from Eisai and funding from Eisai and Sumitomo Dainippon Pharmaceutical. A. Takaori-Kondo has received honoraria from Bristol Myers Squibb, Celgene, Novartis, MSD, Kyowa Kirin, Astellas, and funding from Bristol Myers Squibb, Celgene, COGNANO, Ono, and Thyas, and has received research support from Astellas, Chugai, Eisai, Kim\u2019s Korean Ginseng, Kyowa Kirin, Nippon Shinyaku, Ohara, Ono, Otsuka, Pfizer, Popuri, Takeda, and Sanofi. All other authors do not have any conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}